Read more about Lupin Q4 net profit up 18% at Rs 460 cr; FY21 profit at Rs 1,216 cr on Business Standard. Drug maker Lupin on Thursday reported an 18 per cent increase in its consolidated net profit at Rs 460 crore for the fourth quarter, driven by robust sales across domestic and international markets